A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women

Randall Urban, Johannes D. Veldhuis

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

We investigated serotoninergic regulation of prolactin release in estrogen-withdrawn postmenopausal women by using a serotonin reuptake inhibitor. Subjects underwent frequent blood sampling after placebo (basal) or fluoxetine administration. Mean 24-hour serum prolactin concentrations increased significantly in response to fluoxetine. Objective pulse analysis revealed no change in prolactin pulse frequency with serotoninergic stimulation, but maximal serum prolactin peak heights increased significantly. Multiple-parameter deconvolution disclosed no change in prolactin half-life, but a significant increase in the total mass of prolactin secreted per 24 hours during fluoxetine administration. Cosinor analysis of the prolactin time series showed a significant increase in the circadian amplitude and mean without any change in the time of maximal concentration during treatment with fluoxetine. We conclude that short-term activation of the serotoninergic system in the absence of substantial estradiol and opiatergic tone significantly increases the secretion of prolactin in postmenopausal women.

Original languageEnglish (US)
Pages (from-to)147-152
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume164
Issue number1 PART 1
DOIs
StatePublished - 1991

Fingerprint

Fluoxetine
Serotonin Uptake Inhibitors
Prolactin
Serum
Half-Life
Estradiol
Estrogens
Placebos

Keywords

  • fluoxetine
  • Prolactin
  • pulsatile release
  • serotonin

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

@article{75cfea50c31342ae96865c79f037dda6,
title = "A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women",
abstract = "We investigated serotoninergic regulation of prolactin release in estrogen-withdrawn postmenopausal women by using a serotonin reuptake inhibitor. Subjects underwent frequent blood sampling after placebo (basal) or fluoxetine administration. Mean 24-hour serum prolactin concentrations increased significantly in response to fluoxetine. Objective pulse analysis revealed no change in prolactin pulse frequency with serotoninergic stimulation, but maximal serum prolactin peak heights increased significantly. Multiple-parameter deconvolution disclosed no change in prolactin half-life, but a significant increase in the total mass of prolactin secreted per 24 hours during fluoxetine administration. Cosinor analysis of the prolactin time series showed a significant increase in the circadian amplitude and mean without any change in the time of maximal concentration during treatment with fluoxetine. We conclude that short-term activation of the serotoninergic system in the absence of substantial estradiol and opiatergic tone significantly increases the secretion of prolactin in postmenopausal women.",
keywords = "fluoxetine, Prolactin, pulsatile release, serotonin",
author = "Randall Urban and Veldhuis, {Johannes D.}",
year = "1991",
doi = "10.1016/0002-9378(91)90645-8",
language = "English (US)",
volume = "164",
pages = "147--152",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1 PART 1",

}

TY - JOUR

T1 - A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women

AU - Urban, Randall

AU - Veldhuis, Johannes D.

PY - 1991

Y1 - 1991

N2 - We investigated serotoninergic regulation of prolactin release in estrogen-withdrawn postmenopausal women by using a serotonin reuptake inhibitor. Subjects underwent frequent blood sampling after placebo (basal) or fluoxetine administration. Mean 24-hour serum prolactin concentrations increased significantly in response to fluoxetine. Objective pulse analysis revealed no change in prolactin pulse frequency with serotoninergic stimulation, but maximal serum prolactin peak heights increased significantly. Multiple-parameter deconvolution disclosed no change in prolactin half-life, but a significant increase in the total mass of prolactin secreted per 24 hours during fluoxetine administration. Cosinor analysis of the prolactin time series showed a significant increase in the circadian amplitude and mean without any change in the time of maximal concentration during treatment with fluoxetine. We conclude that short-term activation of the serotoninergic system in the absence of substantial estradiol and opiatergic tone significantly increases the secretion of prolactin in postmenopausal women.

AB - We investigated serotoninergic regulation of prolactin release in estrogen-withdrawn postmenopausal women by using a serotonin reuptake inhibitor. Subjects underwent frequent blood sampling after placebo (basal) or fluoxetine administration. Mean 24-hour serum prolactin concentrations increased significantly in response to fluoxetine. Objective pulse analysis revealed no change in prolactin pulse frequency with serotoninergic stimulation, but maximal serum prolactin peak heights increased significantly. Multiple-parameter deconvolution disclosed no change in prolactin half-life, but a significant increase in the total mass of prolactin secreted per 24 hours during fluoxetine administration. Cosinor analysis of the prolactin time series showed a significant increase in the circadian amplitude and mean without any change in the time of maximal concentration during treatment with fluoxetine. We conclude that short-term activation of the serotoninergic system in the absence of substantial estradiol and opiatergic tone significantly increases the secretion of prolactin in postmenopausal women.

KW - fluoxetine

KW - Prolactin

KW - pulsatile release

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=0026078898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026078898&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(91)90645-8

DO - 10.1016/0002-9378(91)90645-8

M3 - Article

VL - 164

SP - 147

EP - 152

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1 PART 1

ER -